Respiratory

Latest News

Zopapogene imadenovec, a non-replicating adenoviral vector-based immunotherapy, expresses a fusion antigen made up of selected regions of human papillomavirus (HPV) types 6 and 11 proteins. | Image Credit: aznan - stock.adobe.com
FDA Approves Zopapogene Imadenovec for Recurrent Respiratory Papillomatosis

August 19th 2025

The FDA approved zopapogene imadenovec, the first therapy for recurrent respiratory papillomatosis, providing an option beyond repeated surgeries to manage the rare condition.

The results showed a significant improvement in patient-reported symptoms at the 12-month follow-up. | Image credit: doucefleur - stock.adobe.com
Biologics Relieve Ear-Related Symptoms Linked With Asthma, CRwNP

August 16th 2025

Obstructive sleep apnea syndrome. | Image Credit: Chinnapong - stock.adobe.com
Multidisciplinary Approaches to Pediatric Obstructive Sleep Apnea: A Review of Respiratory Therapies

August 13th 2025

Acute respiratory failure. | Image Credit: Selvi - stock.adobe.com
Exploring the Potential of Machine Learning in Optimizing Respiratory Failure Treatment

August 9th 2025

Chronic respiratory disease. | Image Credit: Tipapat - stock.adobe.com
Chronic Respiratory Diseases Linked to Other Noncommunicable Diseases in Vulnerable Countries

August 4th 2025

Continuing Medical Education
View All
August 24th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
August 24th 2025

Managing Patients With COPD: Evidence-Based Care and Optimizing Value of New and Emerging Targeted Therapies

1.0 Credit / Immunology, Pulmonology/Respiratory
August 24th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
August 24th 2025

Updated Guidance and Managed Care Strategies to Optimize Respiratory Syncytial Virus Vaccination Coverage

1.5 Credits / Immunization, Infectious Disease, Pulmonology
August 24th 2025

Reflecting on the Real-World Use of Biologic Therapy in Asthma Management

1.5 Credits / Immunology, Pulmonology
August 24th 2025

Advancing Cystic Fibrosis Management: The Evolving Role of Specialty and Managed Care Pharmacists

1.5 Credits / Pulmonology
August 24th 2025

Pulmonary Arterial Hypertension: Real-World Applications of New Therapies and Management Strategies

1.5 Credits / Pulmonology, Cardiology, Rare Diseases

More News

FDA Inquiring If Some e-Cigarette Makers Are Selling Devices Without Approval
October 13th 2018

FDA Inquiring If Some e-Cigarette Makers Are Selling Devices Without Approval

Allison Inserro
The FDA said Friday it is asking 21 e-cigarette companies for more information about whether more than 40 products, including some flavored e-cigarette products, are being illegally marketed and are outside the agency’s current compliance policy. The move comes a month after the agency warned of a teen vaping epidemic and said it would be cracking down on the sale of the devices to kids.
FDA Approves Arikayce to Treat Certain Patients With Rare Lung Disease
October 11th 2018

FDA Approves Arikayce to Treat Certain Patients With Rare Lung Disease

Alison Rodriguez
The first drug specifically to treat patients with Mycobacterium avium complex, a rare and chronic lung disease, has been approved by the FDA. Arikayce is also the first drug to be approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs, established under the 21st Century Cures Act.
Tackling Antibiotic Prescribers' Behaviors for Respiratory Infections at the VA
October 5th 2018

Tackling Antibiotic Prescribers' Behaviors for Respiratory Infections at the VA

Allison Inserro
An audit feedback intervention is an approach used to help providers translate evidence into behavior change, and at ID Week, 1 abstract showed that it helped reduce antibiotic prescribing for acute respiratory infections (ARIs). Another report showed that antibiotic prescribing rates for ARIs at medical centers operated by the Department of Veterans Affairs (VA) have steadily declined since 2010. ID Week is an annual conference focused on many different infectious disease topics.
Study Finds Gaps in Medicaid Coverage Guidelines for Asthma Care
October 5th 2018

Study Finds Gaps in Medicaid Coverage Guidelines for Asthma Care

Alison Rodriguez
A study found a lack of consistent and comprehensive coverage throughout the country, identified coverage-related challenges to accessing asthma care within states, and found substantial gaps between guidelines-based asthma care and coverage by state Medicaid programs.
What We're Reading: Demand for Antibiotics; FDA Inspects Juul; Fast Food Consumption
October 3rd 2018

What We're Reading: Demand for Antibiotics; FDA Inspects Juul; Fast Food Consumption

AJMC Staff
Patients who receive an antibiotic prescription report being happiest with their doctor’s visit, whether or not they needed the antibiotic; the FDA has collected more than 1000 pages of documents from Juul’s headquarters as part of a surprise inspection into its sales and marketing practices; on any given day, an average of 36.6% of American adults are eating fast food, and the proportion eating fast food increases with income.
Patients Taking Inhaled Steroids May Be at Greater Risk for NTM
September 28th 2018

Patients Taking Inhaled Steroids May Be at Greater Risk for NTM

Alison Rodriguez
Patients who use inhaled steroids to control their asthma or other breathing problems may be at a greater risk for developing nontuberculous mycobacterial lung infections.
The New Era of Telemedicine Brings Positive Health Outcomes for Patients With Asthma
September 28th 2018

The New Era of Telemedicine Brings Positive Health Outcomes for Patients With Asthma

David Bai
A recent meta-analysis shows that combined telemedicine involving telecase management or teleconsultation has significant improvements in asthma control and quality of life.
Draft ICER Report Finds Some Benefit for 5 Biologics to Treat Severe Asthma
September 25th 2018

Draft ICER Report Finds Some Benefit for 5 Biologics to Treat Severe Asthma

Allison Inserro
The Institute for Clinical and Economic Review (ICER) found enough evidence that biologics provide a benefit over the usual standard of care for patients with moderate to severe asthma, the organization said in a draft evidence report released Tuesday. However, since biologics cost much more than other pharmaceutical treatments, ICER said the 5 drugs it reviewed did not meet its usual cost-effectiveness thresholds.
Embarrassment Contributes to Poor Asthma Treatment Adherence, Study Finds
September 22nd 2018

Embarrassment Contributes to Poor Asthma Treatment Adherence, Study Finds

Alison Rodriguez
Despite there being effective therapies, asthma is commonly poorly controlled. Acknowledging and addressing patient treatment beliefs and perceptual barriers to adherence to asthma medication is necessary for designing adherence interventions for patients.
Patients With Asthma–COPD Overlap Have More Severe Disease, Study Finds
September 18th 2018

Patients With Asthma–COPD Overlap Have More Severe Disease, Study Finds

David Bai
Researchers pinpointed the characteristics of asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) causing a greater disease burden than either condition alone.
Associations Between Perceptions of Community Safety With Respiratory Illness Among Low-Income Adults
September 16th 2018

Associations Between Perceptions of Community Safety With Respiratory Illness Among Low-Income Adults

Alison Rodriguez
There is an association between an individual’s perceptions of community safety and adverse respiratory health among populations with exposure to high air pollution, according to new research.
Study Identifies Benralizumab Responders Among COBRA Participants With Severe Asthma
September 12th 2018

Study Identifies Benralizumab Responders Among COBRA Participants With Severe Asthma

David Bai
A retrospective analysis of data from patients with severe asthma who participated in the COBRA trial identified key clinical characteristics that may help clinicians recognize patients who may benefit from additional targeted drug therapy, such as benralizumab.
GSK's Nucala Comes Out Ahead in Comparison of Cinqair, Fasenra, Study Says
September 10th 2018

GSK's Nucala Comes Out Ahead in Comparison of Cinqair, Fasenra, Study Says

Allison Inserro
In an indirect treatment comparison of 3 drugs for severe eosinophilic asthma, GlaxoSmithKline’s (GSK) mepolizumab, marketed as Nucala, reduced exacerbations by 34% to 45% compared with reslizumab or benralizumab. The results were published in The Journal of Allergy and Clinical Immunology.
Genetic Profile and Proximity to Roadways Affect Asthma Symptoms, Study Finds
September 9th 2018

Genetic Profile and Proximity to Roadways Affect Asthma Symptoms, Study Finds

Alison Rodriguez
Patients with asthma with certain genotype combinations demonstrate more intense symptoms when combined with a close proximity to roadways, suggesting that traffic-related air pollution exposure may affect the likelihood of asthma diagnosis and exacerbations.
Security Check Trays Pose Highest Risk of Spreading Respiratory Viruses in Airports
September 7th 2018

Security Check Trays Pose Highest Risk of Spreading Respiratory Viruses in Airports

Laura Joszt, MA
Airports provide multiple sites of risk to contract respiratory viruses, with plastic security screening trays posing the highest potential risk, according to new research published in BMC Infectious Diseases.
Intensive Care Unit Usage for Pneumonia Doubles Length of Hospital Stay
September 6th 2018

Intensive Care Unit Usage for Pneumonia Doubles Length of Hospital Stay

David Bai
A recently released report using data from the National Hospital Care Survey (NHCS) verifies existing data on the prevalence of pneumonia in hospitalizations and emergency department (ED) visits and provides the first-ever data collection on diagnostic testing, length of stay (LOS), intensive care unit (ICU) stays, and mortality.
E-Cigarette Use Prevalent Among Men, People With Comorbidities, Survey Finds
August 31st 2018

E-Cigarette Use Prevalent Among Men, People With Comorbidities, Survey Finds

David Bai
E-cigarette use in the United States is more prevalent in people who are younger, have comorbid conditions, or are former or current conventional cigarette smokers, according to results from a recent Behavioral Risk Factor Surveillance System national report.
Study: Prescribers Unaware of Comorbidity of Nonselective Beta Blockers for Patients With COPD or Asthma
August 30th 2018

Study: Prescribers Unaware of Comorbidity of Nonselective Beta Blockers for Patients With COPD or Asthma

Alison Rodriguez
A substantial number of prescribers did not regard nonselective beta blockers as contraindicated, suggesting the need for improvement programs that target the prescribers’ awareness and knowledge.
Health Organizations React to Rollback of Clean Power Plan Rules
August 22nd 2018

Health Organizations React to Rollback of Clean Power Plan Rules

Allison Inserro
Health organizations reacted with dismay at the decision by the Environmental Protection Agency to reverse the Clean Power Plan, which set limits on coal-fired power plants, and replace it with one called the Affordable Clean Energy Rule, which gives more authority to states in an effort to reduce greenhouse gas emissions. A regulatory impact analysis prepared for the rule indicates 1400 excess deaths created per year by the rule.
Benralizumab Has No Effect on Influenza Vaccine Antibody Response, Study Finds
August 20th 2018

Benralizumab Has No Effect on Influenza Vaccine Antibody Response, Study Finds

David Bai
Benralizumab, an interleukin-5 (IL-5) antagonist used to treat severe asthma, does not weaken antibody response of influenza vaccinations, according to results of a recent study.
Study Probes How Severe Asthma Might Develop Through Allergic Inflammation
August 17th 2018

Study Probes How Severe Asthma Might Develop Through Allergic Inflammation

David Bai
A recent study discovered more about the immunological mechanisms correlated with lung inflammation in some severe asthma patients, raising possibilities it may serve as a baseline for future research and drug development.
FDA Gives Teva Green Light for First Generic EpiPen
August 17th 2018

FDA Gives Teva Green Light for First Generic EpiPen

Allison Inserro
The FDA cleared the first generic version of EpiPen and EpiPen Jr, an epinephrine auto-injector for severe allergic reactions, 2 years after generic drugmaker Teva Pharmaceuticals was first turned down in its bid to win approval for the device. The Teva device is the first-ever generic to the one marketed by Mylan, which is still in short supply during the busy back-to-school season in pharmacies due to production issues at Pfizer, which makes the device.
Lung Cancer Mortality Among Women Projected to Increase 43% by 2030, Study Finds
August 11th 2018

Lung Cancer Mortality Among Women Projected to Increase 43% by 2030, Study Finds

Alison Rodriguez
The global age-standardized lung cancer mortality rate among women is expected to increase by 43% from 2015 to 2030, while the global age-standardized breast cancer mortality rate is projected to decrease by 9%, according to an analysis published in Cancer Research.
In-Person or Video-Based Inhaler Education for Patients With Asthma: Is One Better Than the Other?
August 8th 2018

In-Person or Video-Based Inhaler Education for Patients With Asthma: Is One Better Than the Other?

David Bai
A phase IV noninferiority trial evaluating the difference between video-based and face-to-face inhaler education for patients with asthma did not find a difference in the endpoints that were analyzed. The results were published in PLoS One.
Platelets Regulate Inflammation, Destruction in Tuberculosis, Study Finds
August 6th 2018

Platelets Regulate Inflammation, Destruction in Tuberculosis, Study Finds

Allison Inserro
A recent study found that markers of platelet activity are increased in plasma of patients with pulmonary tuberculosis and these are then normalized with antimycobacterial treatment. The researchers said their findings could have implications for new types of drug therapies.
Nutrition Bar Improves Lung Function in Patients With Both Obesity, Asthma
July 31st 2018

Nutrition Bar Improves Lung Function in Patients With Both Obesity, Asthma

David Bai
Special nutrition bars seem to have a beneficial effect on lung function in patients with noneosinophilic, low-inflammation asthma and obesity, according to a new study.
Researchers Suggest Asthma, ADHD Linked in 2 Studies
July 30th 2018

Researchers Suggest Asthma, ADHD Linked in 2 Studies

Allison Inserro
Both asthma and attention-deficit/hyperactivity disorder (ADHD), both chronic conditions, have been associated with each other in previous studies, but questions remained as to the strength of the association because of other possible confounders. A new review of published data, followed by a population-based study, says the association remains after controlling for possible confounders.
Black Lung Disease Making a Comeback in the United States, Study Finds
July 23rd 2018

Black Lung Disease Making a Comeback in the United States, Study Finds

Allison Inserro
Coal worker’s pneumoconiosis (CWP), commonly called black lung, is making a return, especially in central Appalachia, according to a recent study published in the American Journal of Public Health.
Poor Asthma Control Can Accentuate Risk of Atrial Fibrillation, Study Finds
July 23rd 2018

Poor Asthma Control Can Accentuate Risk of Atrial Fibrillation, Study Finds

David Bai
A new research study, published in JAMA Cardiology, aimed to further confirm a previous correlation between asthma and atrial fibrillation (AF) and to determine if the degree of asthma control affected the risk of developing AF.
Shared Decision-Making Tool Can Identify Best Treatment Plan for Patients With Severe Asthma
July 21st 2018

Shared Decision-Making Tool Can Identify Best Treatment Plan for Patients With Severe Asthma

Laura Joszt, MA
New tools from the American College of Chest Physicians' CHEST Foundation, the Allergy & Asthma Network, and the American College of Allergy, Asthma & Immunology can help clinicians and patients to work together to choose the best treatment and increase adherence.
<1
...
1516171819202122>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo